• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:潘利斌,方罗,王琰.“肠道菌群研究”专栏[J].中国现代应用药学,2024,41(21):51-50.
pan libin,fang luo,wang yan.Advancing Gut Microbiome Research and Fostering Interdisciplinary Integration to Empower Pharmaceutical Development[J].Chin J Mod Appl Pharm(中国现代应用药学),2024,41(21):51-50.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 5次   下载 3 本文二维码信息
码上扫一扫!
分享到: 微信 更多
“肠道菌群研究”专栏
潘利斌1, 方罗1, 王琰2
1.浙江省肿瘤医院;2.中国医学科学院药物研究所
摘要:
近年来,肠道菌群一直是科学研究的前沿热点,特别是从肠道菌群角度研究药物药效和机制,肠道菌群为药学研究注入了全新的视角和方向。为持续推动药学创新,合力公关药学难题,本章推出“肠道菌群研究”专刊,促进多学科融合赋能药学发展。将为广大药学研究同道提供肠道菌群视角下临床借鉴、研究基础和思路拓展,进一步促进药学学科的蓬勃发展。
关键词:  肠道菌群,药学研究
DOI:
分类号:R969.3
基金项目:
Advancing Gut Microbiome Research and Fostering Interdisciplinary Integration to Empower Pharmaceutical Development
pan libin1, fang luo1, wang yan2
1.zhejiang cancer hospital;2.Institue of Materia Medica Chinese Academy of Medical Science
Abstract:
In recent years, the gut microbiota has been at the forefront of scientific research, especially in exploring drug efficacy and mechanisms from the perspective of gut microbiota. This research introduces a new perspective and direction for pharmaceutical studies. To continuously drive pharmaceutical innovation and collaboratively address critical challenges in the field, this chapter launches a special issue on "Gut Microbiota Research." This issue aims to promote interdisciplinary integration, empowering the development of pharmaceutical sciences. It will provide valuable insights, foundational knowledge, and research directions for pharmaceutical researchers, facilitating the advancement of the discipline and contributing to its robust growth.
Key words:  Gut Microbiota, Pharmaceutical Research
扫一扫关注本刊微信